Clinical Trials on Atherothrombosis

Total 16 results

Pierre Fontana
Ministry of Health, France; University Hospital, Montpellier; Swiss National... and other collaborators

Completed

Antiplatelet Drug Resistances and Ischemic Events (ADRIE)

Symptomatic Atherothrombosis

France
Bristol-Myers Squibb

Completed

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

Atherothrombotic Diseases
CSL Limited

Completed

A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

Stable Atherothrombotic Disease

United States
Johns Hopkins University

Completed

Pharmacogenomics of Antiplatelet Response - II (PARes-II) (PARes-II)

Atherothrombosis

United States
University of Edinburgh

Completed

Effect of Real-fire Training on Vascular Function (FIREPROOF)

Vascular Function | Atherothrombosis

United Kingdom
University of Ioannina

Completed

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS) (ASTERIAS)

Atherothrombosis

Greece
Centre Hospitalier Universitaire de la Réunion
Academic Health Science Centres

Unknown

Atherothrombosis Markers in Diabetics (MADI)

Cardiovascular Disease | Diabetes | Atherothrombosis

France
University of Edinburgh

Unknown

Effect of Fire Suppression and Emergency Duties on Vascular Function

Vascular Function | Atherothrombosis

United Kingdom
University of Edinburgh

Unknown

Comparison of Vascular Function in Emergency Service Professionals (FIRECOP)

Vascular Function | Atherothrombosis

United Kingdom
AstraZeneca

Completed

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Myocardial Infarction | Stroke | Atherothrombosis | Cardiovascular Death

Sweden, United States, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Peru, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Philippines, China, Hungary, Romania, U... and more
Hospital do Coracao
Bayer

Active, not recruiting

NEtwork to Control ATherothrombosis (NEAT Registry) (NEAT)

Coronary Artery Disease | Peripheral Arterial Disease | Atherothrombosis

Brazil
Chang Gung Memorial Hospital
National Science Council, Taiwan; Chang Gung University

Unknown

Effects of Aerobic Interval and Continuous Exercise Trainings in Patients With Chronic Heart Failure

Cardiac and Hemodynamic Response | Blood Flow Distribution and Oxygen Uptake Efficiency | Hemorheology Modulated by Erythrocyte | Atherothrombosis Modulated by Monocyte | Angiogenesis Modulated by EPC

Taiwan
National Hospital Organization Osaka National Hospital
Network for Clinical Stroke Trials; The BMS/Pfizer Japan Thrombosis Investigator...

Recruiting

Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF)

Ischemic Stroke | Atrial Fibrillation | Atherothrombosis

Japan
Bayer

Active, not recruiting

Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)

Coronary Artery Disease (CAD) | Prevention of Atherothrombotic Events | Symptomatic Peripheral Artery Disease (Symptomatic PAD)

India
University Hospital, Grenoble

Terminated

Aspirin Resistance and Sleep Apnea in Type-2 Diabetic Patients (AREAS)

Obstructive Sleep Apnea Syndrome | Type 2 Diabetes | Atherothrombosis

France
University of Edinburgh
British Heart Foundation

Completed

In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer (iThrombus)

Myocardial Infarction | Stroke | Thrombosis | Transient Ischemic Attack | Pulmonary Embolism | STEMI | NSTEMI - Non-ST Segment Elevation MI | DVT | PET | Atherothrombosis | Prosthetic Valve Thrombosis

United Kingdom

Clinical Trials on Atherothrombosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations